Metabolic effects of the combination of furosemide and captopril in rat

R. López
C. Taboada
C. Rivas
A. San-Miguel
59

Abstract

Diuretics typically provoke increased serum lipid levels and may provoke increased serum uric acid levels and/or glucose intolerance. Furosemide is widely used as an antihypertensive, but in patients for whom furosemide treatment alone
proves insufficient to reduce hypertension, a common procedure is to co-administer the angiotensin-converting-enzyme (ACE) inhibitor captopril. The metabolic effects in rats of joint administration of furosemide (15 mg/kg/day) and captopril
(2 mg/kg/day) are evaluated over a two-week period. At the end of this period, the serum levels of lipids, uric acid, bilirubin, proteins and various enzymes were determined as well as the effect of the treatment on intestinal absorption of glucose and calcium. Furosemide/captopril led to an increase in serum albumin and alkaline phosphatase levels, and a decrease in triglyceride levels. The results of this work support the view that this drug combination is suitable for hypertension treatment.

Keywords:
Furosemide, Captopril, Glucose, Lipids, Calcium

Authors

R. López
C. Taboada
C. Rivas
A. San-Miguel

References

Ambrosini, E., Borghi, C. and Costa, V. (1987): Br.J. Clin. Pharmacol, 23, 43-50. https://doi.org/10.1111/j.1365-2125.1987.tb03121.x

Ames, R. P. and Hill, P. (1982): J. Cardiovasc.Pharmacol, 4, 206-212.

Ames, R. P. (1983): Ara. Heart J., 106, 1207- 1214. https://doi.org/10.1016/0002-8703(83)90176-X

Ames, R. P. and Peacock, P. (1994): Arch. Intern. Med., 144, 710-714. https://doi.org/10.1001/archinte.144.4.710

Barba, G., Strazullo, P., Galleti, A. S., Di Carlo, A. and Mancini, M. (1992): Cnrr. Ther. Res., 52, 524-531. https://doi.org/10.1016/S0011-393X(05)80458-8

Bianchi, S., Bigazzi, R., Baldiri, G., and Campese, V. (1992): Am. J. Med., 93, 525-528. https://doi.org/10.1016/0002-9343(92)90580-5

Bushinsky, D., Favus, M., Langman, B. and Coef, L. (1986): Am. J. Physiol, 251, F17-F24. https://doi.org/10.1152/ajprenal.1986.251.1.F17

Buzio, C., Rcgolisti, G., Perazzoli, F., Bergamascchi, E. and Borghetti, A. (1994): Hypertension, 24, 763-769. https://doi.org/10.1161/01.HYP.24.6.763

Chrysant, S. G., Brown, R. D., Kem, D., and Brown, J. L. (1983): Clin. Pharmacol. Ther., 33, 741-746. https://doi.org/10.1038/clpt.1983.101

Erley, C. M., Haefele, U., Heyne, N., Braun, N. and Risler, T. (1993): Hypertension, 21, 810-815. https://doi.org/10.1161/01.HYP.21.6.810

Griffing, G. T. and Melby, J. C. (1982): Ctirr.Ther. Res., 32, 396-405. https://doi.org/10.1038/clpt.1982.208

Joos, C., Kewitz, H. and Reinhold-Kourniati, D. (1980): Enr. J. Clin. Pharmacol, 17, 251-257. https://doi.org/10.1007/BF00625798

Keller, U., Weiss, M. and Stauffacher, W. (1989): Diabetes, 38, 454-459. https://doi.org/10.2337/diabetes.38.4.454

Koffer, H., Vlasses, P. H., Ferguson, R. K., Weis, M. and Adler, A. G. (1980): JAMA, 244, 2532-2535. https://doi.org/10.1001/jama.244.22.2532

Lasser, N. L., Grandits, G. and Caggiula, A.W.(1984): Am. J. Med., 27, 52-66. https://doi.org/10.1016/0002-9343(84)90957-4

Levy, B. (1977): J. Clin. Pharmacol, 34, 420- 430. https://doi.org/10.1002/j.1552-4604.1977.tb04625.x

Lithell, H. (1991): Diabetes Care, 14, 203-209. https://doi.org/10.2337/diacare.14.3.203

Malini, P. L., Strocchi, E., Ambrosini, E. and Magnani, B. (1984): J. Hypertens., 2, 101-105.

Middlemost, S. J., Tager, R., Davis, J. and Sarcli, P. (1994): Am. J. Cardiol, 73, 1092-1097. https://doi.org/10.1016/0002-9149(94)90289-5

Okssa, A., Stefikova, V., Fedelesova, V., Baculakova, V., Spustova, V. and Dzurik, R. (1992): Cor. Vasa, 34, 329-431.

Perola, P., Lehto, H., Lammintausta, R. and Viikari, J. (1985): Curr. Ther. Res., 37, 545-553.

Ponz, F., Ilundain, A. and Lluch, M. (1979): Rev. esp. Fisiol, 35, 97-104.

Pors Nielsen, S., Andersen, O. and Steven, K. E. (1969): Acta Pharmacol Toxicol, 27, 469-479. https://doi.org/10.1111/j.1600-0773.1969.tb00495.x

Prichard, B. N., Owens, W. I. and Woolf, A. S. (1992): Eur. Heart J., 13, 96-103. https://doi.org/10.1093/eurheartj/13.suppl_G.96

Sica, D. (1994): Drugs, 48, 17-24. https://doi.org/10.2165/00003495-199448010-00003

Scott, J. and Higgens, C. (1992): Ann. Rheti. Dis., 51,259-261. https://doi.org/10.1136/ard.51.2.259

Townsend, R. and Holland, B. (1990): Arch. Intern. Med., 150, 1175-1183. https://doi.org/10.1001/archinte.150.6.1175

Warshaw, B. L., Anand, S. K., Kerian, A. and Lieberman, J. (1980): Pediatr. Res., 14, 1118- 1121. https://doi.org/10.1203/00006450-198010000-00006

Weidman, P., Beretta-Picoli, C., Meier, A., Keusch, G., Gluck, Z. and Ziegler, W. H. (1983): Kidney Intern., 23, 320-326. https://doi.org/10.1038/ki.1983.22

Weidman, P., Courten, M. and Ferrari, P. (1992): Eur. Heart J., 13, 61-67. https://doi.org/10.1093/eurheartj/13.suppl_G.61

Winberger, M. H. (1983): Hypertension, 5, 132- 138.

Youssef, S., Osman, L. and Sabour, M. S. (1992): Int.J. Clin. Pharm. Res., 12, 109-116


Metrics

Search GoogleScholar



Downloads

Download data is not yet available.

Section

Articles